400-920-2911 sales@csnpharm.cn
CAS No.: 1037792-44-1
Synonyms: SAR-260093
MBX-2982 is a selective, orally-available GPR119 agonist for the treatment of type 2 tiabetes.
规格 | 价格 | 促销价格 | 库存 | 数量 |
---|
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01035879 | Diabetes | Phase 2 | Completed | - | United States, California ... more >> Impact Clinical Trials Los Angeles, California, United States, 90036 United States, Nevada Nevada Alliance Against Diabetes Las Vegas, Nevada, United States, 89101 United States, New York United Medical Associates Binghamton, New York, United States, 13901 United States, Texas dgd Research, Inc., a Cetero Research Co. San Antonio, Texas, United States, 78229 Georgia Healthy Life Clinical Diagnostic Center Tbilisi, Georgia, 0144 Georgian Diabetes Center Tbilisi, Georgia, 0159 Medulla Chemotherapy and Immunotherapy Clinic Tbilisi, Georgia, 0186 India Bharti Research Institute of Diabetes and Endocrinology Karnal, Haryana, India, 132001 Diabetes Thyroid Hormone Research Institute Pvt Ltd Indore, M.p., India, 452001 Gandhi Endocrinology & Diabetes Centre Ramdaspeth, Nagpur, India, 10 Gokula Metropolis Research, MS Ramaiah Memorial Hospital Bangalore, India, 560 054 Medisys Clinisearch India Pvt Ltd Bangalore, India, 560043 Hormone Care Research Centre Ghaziabad, India, 201002 Bangalore Endocrinology & Diabetes Research Centre Malleshwaram, India, 560 003 Collapse << |
实验方案
技术信息
CAS号 | 1037792-44-1 | 储存条件 |
|
|||||
分子式 | C22H24N8OS | 运输 | 蓝冰 | |||||
分子量 | 448.54 | 别名 | SAR-260093 | |||||
溶解度 |
|
动物实验配方 |